Insider buying last 90 days
No open-market insider purchases were filed for SHC in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every SHC insider filing, plotted on the chart in Gekko.Open SHC in Gekko
NASDAQ: SHC
Sotera Health (SHC) Stock Analysis & Forecast
Sep 28 close
$18.45+0.11 (+0.6%)
Gekko Brief
AI summarySotera Health's stock draws attention this week after Q2 2026 results showed revenue growing 9.2% year-over-year to $321.375 million, with net income rising to $54 million from $8 million a year earlier. Coverage also notes short-term momentum cooling, with shares down 6.25% over the past month even as longer-term returns stay positive. A separate revenue breakdown highlights Sterigenics as the top-performing segment, alongside the United States as the largest regional contributor.
Shares closed at $18.45, up 0.6%, sitting between the 50-day average of $18.55 and the 200-day average of $16.96, a mixed trend signal. The GekkoIndex reads 61, placing SHC in the Accumulation zone. Price stands 8.7% below Gekko Fair Value of $20.21, a gap that leaves room between current trading levels and that estimate.
Sotera Health's next earnings report is set for 3 November 2026, 35 days out and beyond a typical 20-trading-day holding window. No insider, Congress or unusual options activity appears in the current windows, though one billionaire holder and five trailblazer holders are noted. Seasonality over the past 5 years shows the next 20 trading days averaging -5.8%, with gains in just 1 of those years, a pattern worth noting alongside the six analyst firms currently rating the stock a buy.
Written by AI and checked automatically against the figures on this page. Generated Sep 29, 2026 from the data above.
Sotera Health price vs fair value
Close $18.45200-day averageGekko Fair Value $20.21
Sotera Health quick facts
- Market cap
- $5.26B
- P/E ratio
- 31.8
- Forward P/E
- 17.8
- EPS, TTM
- $0.58
- Revenue, TTM
- $1.22B
- Profit margin
- 13.4%
- Dividend yield
- —
- Beta
- 1.78
- Volume
- 1.39M avg 1.95M
- 1-year return
- +18.7%
- Typical daily move
- ±2.4%
- Typical 20-day move
- ±7.3%
- 50-day average
- $18.55
- 200-day average
- $16.96
- Next earnings
- Nov 3 before open
- Shares outstanding
- 285.4M
Sotera Health swing-trade checklist
Sotera Health scores 3 supportive, 1 mixed and 1 headwind across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive1 mixed1 headwind
- Trendmixed
Averages disagree
Close $18.45 sits between the 50-day ($18.55) and 200-day ($16.96) averages, or the averages disagree.
See the chart - GekkoIndexsupportive
61, Accumulation
Reading 61 is in the Accumulation zone.
See the GekkoIndex - Fair valuesupportive
8.7% below
Price is 8.7% below Gekko Fair Value (more than 5% below).
See fair value - Smart moneyno data
No data
No insider, Congress or unusual options activity in the window.
See smart money - Earnings risksupportive
Reports in 35 days
Next report Nov 3, 2026, 35 days away — outside a typical 20-trading-day hold.
See earnings - Seasonalityheadwind
−5.8% on average
From this point in the calendar, the next 20 trading days averaged −5.8% over 5 years, rising in 1 of them.
See seasonality
A description of current data, not a recommendation. How this page works
Sotera Health stock chart and price history
Sotera Health closed at $18.45 on Sep 28, 2026, +18.7% over the past year, inside a 52-week range of $13.09 to $19.85.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- −5.3%
- 3 months
- +5.3%
- 6 months
- +40.5%
- 1 year
- +18.7%
The full SHC chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open SHC in Gekko
Follow Sotera Health through every session
Put SHC on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track SHC in GekkoFree for 7 days. No credit card required.
About Sotera Health
Sotera Health provides sterilization, laboratory testing, and advisory work to clients across North America, Europe, and other international markets. Its sterilization methods include gamma and electron beam irradiation as well as ethylene oxide processing, and it is recognized for these treatment services alongside the microbiological and analytical chemistry testing carried out through its Nelson Labs division.
The company also provides specialized consulting aimed at the medical device and biopharmaceutical fields. Its customer base spans medical device makers, pharmaceutical firms, food and agricultural producers, and a range of commercial, advanced, and specialty application industries, reflecting a mix of testing, treatment, and advisory work built around these different client groups.
Sotera Health was incorporated in 2017 under the name Sotera Health Topco, Inc., before taking its present name in October 2020. It is headquartered in Broadview Heights, Ohio, and its shares are listed on the NASDAQ under the ticker SHC.
- Listed
- NASDAQ
- Sector
- Health technology
- Industry
- Medical specialties
- Website
- soterahealth.com
Sotera Health GekkoIndex: the smart money zone
Sotera Health’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 61, in the Accumulation zone, up 1.4 points over five sessions.
61Accumulation
Up 1.4 points over five sessions, from the Neutral zone.
Reading for Sep 28, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 50 | −1.4% | −0.2% | ||
| Accumulation (current zone) | 208 | +1.2% | +2.2% | ||
| Neutral | 359 | 0.0% | +1.5% | ||
| Distribution | 51 | +0.4% | −1.4% | ||
| Selling | 4 | Too few readings yet | |||
Average SHC share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.3% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
See every daily GekkoIndex reading plotted over the SHC price, zone by zone.Track SHC in Gekko
Is Sotera Health stock overvalued? Gekko Fair Value
Sotera Health trades 8.7% below Gekko Fair Value of $20.21, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Sotera Health shares are worth, recalculated every trading day.
$20.21
Gekko Fair Value, Sep 26, 2026
8.7% Undervalued
Gekko Fair Value on every chart, with the gap to price updating daily.Open SHC in Gekko
Sotera Health insider and Congress trading
No open-market insider purchases were filed for Sotera Health, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in SHC were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for SHC, plotted on the chart in Gekko.Open SHC in Gekko
Buybacks
Sotera Health has been buying back its own shares.
- Bought back, quarter ended Jun 30, 2025
- $54K
- As a share of market cap
- 0.00%
From company filings.
Hedge funds and billionaires quarter ended Jun 30
6of the funds Gekko tracks hold SHC.
4added1opened1trimmed0sold out
Which funds are on each side, name by name.Unlock in Gekko
Sotera Health earnings: next date and track record
Sotera Health reports on Nov 3, 2026, before the open (35 days away), and beat the EPS estimate in 7 of its last 8 reports.
Next earnings report
Nov 3, 2026
Expected before the open, 35 days away
- EPS estimate
- $0.27
- Revenue estimate
- $319.8M
7 of 8reports beat the EPS estimate
±8.7%average move across the report
5 of 8reports followed by a gain
Share-price move across each report
Last earnings call, May 5, 2026 AI summary
- What they said
- Sotera Health reported Q1 2026 constant currency revenue growth of 6.5% and adjusted EBITDA growth of 6.9%, with 20+ basis points of margin expansion. Sterigenics grew 6.1% in constant currency, while Nordion surged 25.8% with 290+ basis points of margin expansion. Nelson Labs performed in line with expectations. Public float reached ~90% after PE secondary sale. All eight Georgia bellwether personal injury cases were dismissed.
- Guidance
- Management reaffirmed 2026 full-year guidance: revenue of $1.23B–$1.25B (5%–6.5% constant currency growth) and adjusted EBITDA of $632M–$641M (5.5%–7% constant currency growth) versus 2025.
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| May 5, 2026 | $0.18 est $0.17 | $280.0M est $270.8M | +2.7% |
| Feb 24, 2026 | $0.26 est $0.24 | $303.4M est $299.5M | −7.6% |
| Nov 4, 2025 | $0.26 est $0.22 | $311.3M est $299.6M | −4.8% |
| Aug 8, 2025 | $0.20 est $0.17 | $294.3M est $305.0M | +25.3% |
| May 1, 2025 | $0.14 est $0.12 | $254.5M est $276.9M | +7.7% |
| Feb 27, 2025 | $0.21 est $0.20 | $290.2M est $259.7M | −8.6% |
| Nov 5, 2024 | $0.17 est $0.18 | $285.5M est $291.8M | +2.0% |
| Aug 5, 2024 | $0.19 est $0.16 | $276.6M est $266.4M | +11.2% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Sotera Health stock forecast and analyst price targets
Analysts’ average 12-month price target for Sotera Health is $22.72, +23.1% from the last close, from 6 firms rating the stock in the last 90 days.
$22.72consensus 12-month target, +23.1% from the last close
Now $18.45Avg $22.72
Low $22High $25
Each firm’s latest rating in the last 90 days: 6 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 18 | Piper Sandler | $25 | +35.5% |
| Sep 8 | Piper Sandler | $25 | +35.5% |
| Aug 7 | Piper Sandler | $25 | +35.5% |
| Aug 7 | Citi | $25 | +35.5% |
| Aug 7 | Barclays | $22 | +19.2% |
+2.2%average 20-day move after past Accumulation readings
−5.8%average move over the next 20 trading days in the last 5 years
±2.4%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Sotera Health seasonality: the next 20 trading days
Over the next 20 trading days from Sep 29, Sotera Health averaged −5.8% across the last 5 years, rising in 1 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | −1.7% | 1 of 5 |
| Next 10 trading days | −5.3% | 0 of 5 |
| Next 15 trading days | −3.6% | 1 of 5 |
| Next 20 trading days | −5.8% | 1 of 5 |
| Next 30 trading days | −5.5% | 0 of 5 |
For scale, SHC’s typical 20-trading-day move in either direction is about 7.3%.
Sotera Health market cap and key statistics
Sotera Health’s market cap is $5.26B, with a P/E ratio of 31.8 and revenue of $1.22B over the last twelve months.
Valuation
- Market cap
- $5.26B
- P/E ratio
- 31.8
- Forward P/E
- 17.8
- EPS, TTM
- $0.58
- Gekko Fair Value
- $20.21
Trading
- Volume
- 1.39M
- Avg volume, 20 days
- 1.95M
- 52-week high
- $19.85
- 52-week low
- $13.09
- Shares outstanding
- 285.4M
Financials
- Revenue, TTM
- $1.22B
- Profit margin
- 13.4%
- Return on equity
- 27.8%
- Quarterly earnings growth, YoY
- +570.0%
Risk and income
- Beta
- 1.78
- Typical daily move
- ±2.4%
- Typical 20-day move
- ±7.3%
Sotera Health stock news this week
Coverage of Sotera Health this week reads positive: 2 positive, 2 neutral and 0 negative headlines.
- Sotera Health stock reports 9.2 percent revenue growth in Q2AD HOC NEWS, Sep 25
- Sotera Health (SHC) Looks Cheaper As Short Term Momentum CoolsSimply Wall Street, Sep 24
- Squarepoint Ops LLC Sells 102,776 Shares of Sotera Health Company $SHCDefense World, Sep 24
- Sotera Health Company (SHC) Stock Price, News, Quote & HistoryYahoo! Finance Canada, Sep 23
- Sotera Health Company Revenue Breakdown – LS:A2QHA5TradingView, Sep 21
Sotera Health peers
Sotera Health’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| TMOThermo Fisher Scientific | Distribution | 23.7% above |
| ABTAbbott Laboratories | Accumulation | 15.0% below |
| DHRDanaher | Distribution | 10.2% above |
| ISRGIntuitive Surgical | Neutral | 17.0% above |
| MDTMedtronic | Accumulation | 24.1% below |
| SYKStryker | Accumulation | 14.1% below |
A peer links to its own page where one exists.
Sotera Health stock FAQ
What is Sotera Health’s market cap?
Sotera Health’s market cap is $5.26B at the Sep 28, 2026 close of $18.45, with 285.4M shares outstanding. The shares trade on a P/E ratio of 31.8.
What is the Sotera Health stock forecast?
The consensus analyst 12-month price target for Sotera Health is $22.72, +23.1% from the last close. Of the 6 firms that rated the stock in the last 90 days, 6 rate it a buy, 0 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is Sotera Health stock overvalued or undervalued?
On Gekko’s estimate Sotera Health is undervalued: the Sep 28, 2026 close of $18.45 is 8.7% below Gekko Fair Value of $20.21. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does Sotera Health report earnings next?
Sotera Health is expected to report on Nov 3, 2026, before the market opens (35 days away). Analysts expect earnings of $0.27 per share on revenue of $319.8M. Sotera Health beat the earnings estimate in 7 of its last 8 reports, moving 8.7% on average across the report.
What is Sotera Health’s 52-week high and low?
Sotera Health’s 52-week high is $19.85 and its 52-week low is $13.09; it closed at $18.45 on Sep 28, 2026, +18.7% over the past year. Over the last five years the shares peaked at $27.38 on Nov 4, 2021.
Is Sotera Health stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (gekkoindex, fair value and earnings risk), 1 as mixed (trend) and 1 as a headwind (seasonality). The checklist is a description of current data, not a recommendation.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See Sotera Health the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,380 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.